Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form
- PMID: 28861497
- PMCID: PMC5531365
- DOI: 10.1089/can.2016.0022
Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form
Abstract
Introduction: Rates of cannabis use disorder (CUD) among vulnerable populations have increased in recent years, highlighting a need to equip providers with an efficient screening tool. Materials and Methods: A short form of the Cannabis Use Disorder Identification Test-Revised (CUDIT-R) was developed by using item response theory and traditional statistical methods, with data from two community samples of cannabis users representing two countries. Four item selection methods (Rasch regression, test characteristic curve, logistic regression, discriminant function analysis) were employed to identify the optimal three-item shortened version. The diagnostic ability of the short form was evaluated by using receiver operating characteristic curves. Results: Using a cut score of 2, the 3-item CUDIT-Short Form (CUDIT-SF; reliability alpha=0.66, Sample 1; 0.80, Sample 2) identified 78.26% of participants in Sample 1 and 78.31% of participants in Sample 2 who met DSM-5 criteria for CUD, with 98% agreement in Sample 1 and 93% agreement in Sample 2 with the full CUDIT-R on CUD classifications using a cut score of 13. Specificity was 76.70 and 78.00 in Samples 1 and 2, respectively. Conclusions: The CUDIT-SF may be useful in busy clinical settings for a stepwise screening. Further validation of this shortened version with larger samples and in different settings is warranted.
Keywords: assessment; cannabis; cannabis use disorder; screening.
Conflict of interest statement
No competing financial interests exist.
Similar articles
-
Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use.Drug Alcohol Depend. 2023 Jun 1;247:109876. doi: 10.1016/j.drugalcdep.2023.109876. Epub 2023 Apr 14. Drug Alcohol Depend. 2023. PMID: 37130467
-
Screening for cannabis use disorder among young adults: Sensitivity, specificity, and item-level performance of the Cannabis Use Disorders Identification Test - Revised.Addict Behav. 2024 Jan;148:107859. doi: 10.1016/j.addbeh.2023.107859. Epub 2023 Sep 9. Addict Behav. 2024. PMID: 37717499
-
Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample.Drug Alcohol Rev. 2021 Nov;40(7):1334-1339. doi: 10.1111/dar.13298. Epub 2021 Apr 14. Drug Alcohol Rev. 2021. PMID: 33855757
-
[Screening tools for cannabis use disorders and their adaptation to DSM-5: A literature review].Encephale. 2020 Oct;46(5):382-389. doi: 10.1016/j.encep.2020.02.010. Epub 2020 May 28. Encephale. 2020. PMID: 32475691 Review. French.
-
Short scales to assess cannabis-related problems: a review of psychometric properties.Subst Abuse Treat Prev Policy. 2008 Dec 2;3:25. doi: 10.1186/1747-597X-3-25. Subst Abuse Treat Prev Policy. 2008. PMID: 19055741 Free PMC article. Review.
Cited by
-
Sources of cannabis among young adults and associations with cannabis-related outcomes.Int J Drug Policy. 2020 Dec;86:102971. doi: 10.1016/j.drugpo.2020.102971. Epub 2020 Oct 7. Int J Drug Policy. 2020. PMID: 33038599 Free PMC article.
-
Motor Adaptation Impairment in Chronic Cannabis Users Assessed by a Visuomotor Rotation Task.J Clin Med. 2019 Jul 18;8(7):1049. doi: 10.3390/jcm8071049. J Clin Med. 2019. PMID: 31323815 Free PMC article.
-
Priming primary care providers to engage in evidence-based discussions about cannabis with patients.Addict Sci Clin Pract. 2019 Dec 2;14(1):42. doi: 10.1186/s13722-019-0171-3. Addict Sci Clin Pract. 2019. PMID: 31787111 Free PMC article. Review.
-
Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions.Psychiatry Clin Psychopharmacol. 2024 Mar 1;34(1):82-93. doi: 10.5152/pcp.2024.23645. eCollection 2024 Mar. Psychiatry Clin Psychopharmacol. 2024. PMID: 38883882 Free PMC article. Review.
-
Cannabis Use Differences Among Sexual Minority Versus Heterosexual Females and Males in Oklahoma: The Roles of Mental Health, Cannabis Perceptions, and Cannabis Marketing Exposure.Subst Use Addctn J. 2024 Jan;45(1):101-113. doi: 10.1177/29767342231208519. Subst Use Addctn J. 2024. PMID: 38258857 Free PMC article.
References
-
- United Nations Office on Drugs and Crime. World drug report 2014 (United Nations publication, Sales No. E.14.XI.7). Vienna, Austria: United Nations Office on Drugs and Crime, 2014
-
- Substance Abuse and Mental Health Services Administration. Results from the 2013 national survey on drug use and health: summary of national findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014
-
- Australian Institute of Health and Welfare. National drug strategy household survey detailed report 2013. Drug statistics series no. 28. Cat. no. PHE 183. Canberra, Australia: Australian Institute of Health and Welfare, 2014
-
- Bonn-Miller MO, Harris AH, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv. 2012;9:404–416 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous